Cargando…

Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer

Detalles Bibliográficos
Autores principales: Wang, Dong, Du, Ruikai, Liu, Suling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372300/
https://www.ncbi.nlm.nih.gov/pubmed/28359295
http://dx.doi.org/10.1186/s40880-017-0204-9
_version_ 1782518588215656448
author Wang, Dong
Du, Ruikai
Liu, Suling
author_facet Wang, Dong
Du, Ruikai
Liu, Suling
author_sort Wang, Dong
collection PubMed
description
format Online
Article
Text
id pubmed-5372300
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53723002017-03-30 Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer Wang, Dong Du, Ruikai Liu, Suling Chin J Cancer Research Highlight BioMed Central 2017-03-30 /pmc/articles/PMC5372300/ /pubmed/28359295 http://dx.doi.org/10.1186/s40880-017-0204-9 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Highlight
Wang, Dong
Du, Ruikai
Liu, Suling
Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
title Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
title_full Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
title_fullStr Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
title_full_unstemmed Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
title_short Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
title_sort rad51 inhibition sensitizes breast cancer stem cells to parp inhibitor in triple-negative breast cancer
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372300/
https://www.ncbi.nlm.nih.gov/pubmed/28359295
http://dx.doi.org/10.1186/s40880-017-0204-9
work_keys_str_mv AT wangdong rad51inhibitionsensitizesbreastcancerstemcellstoparpinhibitorintriplenegativebreastcancer
AT duruikai rad51inhibitionsensitizesbreastcancerstemcellstoparpinhibitorintriplenegativebreastcancer
AT liusuling rad51inhibitionsensitizesbreastcancerstemcellstoparpinhibitorintriplenegativebreastcancer